Why do the platforms gate healthcare?
Ad platforms carry real liability for illegal pharmacy promotion, and each solved it the same way: outsource merchant verification to a third party, then police creative separately. That's why LegitScript certification (or, for pharmacies, NABP accreditation) shows up in every major platform's healthcare policy: the platform verifies that you're certified, and certification verifies everything else about you.
The two-layer structure matters practically. Certification gets your account eligible to run prescription-related campaigns; it says nothing about whether a specific ad passes review. Operators who clear the first gate and then run weight-loss creative written like supplement marketing discover the second gate immediately.
Certification is the ticket into the auction. The claims discipline is what keeps you in it. Budget effort for both, in that order.
Google: what does certification require?
Google's healthcare and medicines policy requires online pharmacies and telemedicine providers targeting the U.S. to be certified before running ads, and LegitScript certification is the named pathway. The sequence is: get certified first, then apply for Google's healthcare-related certification through its own application, then run. Prescription drug terms in keywords and ad copy are restricted to certified advertisers, and some substances stay prohibited for everyone.
Two Google-specific traps recur. First, the certification is scoped: it covers the verified advertiser and the domains disclosed, so a new domain or a rebrand needs the paperwork updated before ads point at it. Second, Google's automated checks compare the ad, the keyword, and the landing page; a compliant ad pointing at a page with equivalence claims or missing disclosures fails on the landing-page side, which is the half operators forget to audit.
TikTok and the rest: what are the rules?
TikTok is the most restrictive of the big three for this category: prescription drug promotion is broadly prohibited, and weight-management advertising is restricted with age-targeting requirements where it's allowed at all. Some telehealth brands run TikTok successfully with condition-education and brand creative that routes to compliant funnels, but building a plan that depends on running Rx product ads on TikTok is, as of August 2026, building on policy you don't have.
Microsoft Advertising broadly mirrors Google's structure, including third-party certification for pharmacy-related advertisers. Across every platform, assume the same skeleton: verify the merchant through a certifier, restrict drug terminology to the verified, police creative claims for everyone.
Why do certified advertisers still get disapproved?
Certification removes the eligibility problem and none of the creative problems. The disapprovals that survive certification, in rough order of frequency:
- Outcome claims the evidence can't carry: guarantees, specific weight-loss numbers borrowed from brand-name clinical trials, 'permanent' results.
- Before-and-after imagery and transformation testimonials in prohibited categories.
- Personal-attribute copy that addresses the viewer's condition instead of describing the product.
- Landing-page mismatch: compliant ad, non-compliant destination (missing compounded disclosures, equivalence claims, prices for prescription drugs where policy restricts them).
- Drug names used in creative without the certification scope or platform permission that allows them.
- Cloaking or funnel-swapping, which platforms treat as a trust violation worth an account ban rather than an ad rejection.
Read every disapproval as naming one of two layers: eligibility (fix paperwork and scope) or creative (fix the claim). Appealing without knowing which layer you're in wastes the appeal.
Where does EmbedCare fit?
EmbedCare's growth engine ships partner brands with the funnel architecture this policy landscape demands: landing pages built to the certification standards, intake behind the ad click rather than claims in it, pixels behind consent, and creative guardrails drawn from running certified brands of our own. Before you spend on traffic, run your landing pages through our free Preflight scanner; the same findings that block certification are the ones ad review reads on the other side of your ads.
Frequently asked
- Do I need LegitScript certification to run telehealth ads?
- For prescription-related campaigns targeting the U.S. on Google and Meta, effectively yes as of August 2026: both platforms gate pharmacy and prescription-drug advertising behind certification (Google also runs its own healthcare certification application on top). Pure wellness advertising without prescription products has more room, but the moment Rx enters the funnel, the gate applies.
- Why are my ads still disapproved after certification?
- Certification settles who may advertise, not what the ads may say. Most post-certification disapprovals are creative-layer: outcome claims, before-and-after imagery, personal-attribute copy, or a landing page that contradicts policy. Fix the specific claim and the same account runs fine.
- Can I mention drug names like semaglutide in ad copy?
- Only within each platform's rules for certified advertisers, and the details differ by platform and campaign type. Uncertified accounts using prescription drug terms is one of the fastest routes to disapproval, and equivalence phrasing ('same as' a brand drug) is a claims violation even for certified accounts.
- Does certification cover all my ad accounts and domains?
- It covers what you disclosed. Platforms verify certification against specific advertiser identities and domains, so new domains, rebrands, or agency-held accounts need the registration updated before campaigns point at them.
Want pricing for your program, and the Rx menu that goes with this?
The partner overview in one email; a human follows up with pricing scoped to your program.